395 related articles for article (PubMed ID: 27614591)
1. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
[TBL] [Abstract][Full Text] [Related]
2. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
Robert MC; Pomerleau V; Harissi-Dagher M
Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
[TBL] [Abstract][Full Text] [Related]
3. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
[TBL] [Abstract][Full Text] [Related]
5. Technique of combined glaucoma tube shunt and keratoprosthesis implantation.
Law SK; Huang JS; Nassiri N; Moghimi S; Nilforushan N; Parham A; Moossai J; Kim M; Caprioli J; Aldave AJ
J Glaucoma; 2014; 23(8):501-7. PubMed ID: 25275831
[TBL] [Abstract][Full Text] [Related]
6. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
[TBL] [Abstract][Full Text] [Related]
7. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
8. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
[TBL] [Abstract][Full Text] [Related]
9. Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation.
Cortina MS; Karas FI; Bouchard C; Aref AA; Djalilian A; Vajaranant TS
Ocul Surf; 2019 Apr; 17(2):336-340. PubMed ID: 30742989
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
12. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
13. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
Aoun T; Harissi-Dagher M
J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
[TBL] [Abstract][Full Text] [Related]
14. Boston type 1 keratoprosthesis for primary congenital glaucoma.
Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
Kaufman AR; Cruzat A; Colby KA
Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
[TBL] [Abstract][Full Text] [Related]
17. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
[TBL] [Abstract][Full Text] [Related]
19. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
[TBL] [Abstract][Full Text] [Related]
20. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
